![Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders - ScienceDirect Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572819303753-ga1.jpg)
Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders - ScienceDirect
![Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/97343738-f909-4e28-94e4-b624973cd798/hsr2113-fig-0001-m.jpg)
Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease - Yang - 2019 - Health Science Reports - Wiley Online Library
![International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.307/MediaObjects/41375_2009_Article_BFleu2008307_Fig1_HTML.jpg)
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig1_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
![Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10354-022-00912-7/MediaObjects/10354_2022_912_Fig1_HTML.png)
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift
![Figure 1 from Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar Figure 1 from Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/091b9510bd72aa951da79457a27309803520cd7e/2-Figure1-1.png)
Figure 1 from Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar
![Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation](https://www.neurology.org/cms/10.1212/NXI.0000000000200049/asset/2427c45f-1380-45a4-9230-07b1fb102594/assets/graphic/nxi.0000000000200049f1.jpeg)
Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
![Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram](https://www.researchgate.net/publication/292707470/figure/fig2/AS:324773960798244@1454443555010/Measurement-of-kappa-k-and-lambda-l-light-chains-in-free-and-total-assays-Total.png)
Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram
![Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine](https://www.thelancet.com/cms/attachment/0a6d90ba-3e1a-443c-868c-fdb5b660e884/gr1.jpg)
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
![Case study: The hook effect in serum free ligh chain assay | The Biomedical Scientist Magazine of the IBMS Case study: The hook effect in serum free ligh chain assay | The Biomedical Scientist Magazine of the IBMS](https://thebiomedicalscientist.net/sites/default/files/web_28-29_hires-cmyk-retouched-science_photo_library_c0491397.jpg)
Case study: The hook effect in serum free ligh chain assay | The Biomedical Scientist Magazine of the IBMS
![IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases](https://www.mdpi.com/ijms/ijms-24-09531/article_deploy/html/images/ijms-24-09531-g001.png)
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig2_HTML.png)